Zydus Lifesciences Discontinued
FDA Approved Drugs
Zydus Lifesciences Discontinued
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 31
- Latest Approval Date Aug 07, 2024
- Data Source FDA
- First Approval Date Oct 10, 2012
Company Overview
Social Profiles
Company Snapshot
Zydus Lifesciences Discontinued
Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Sarkhej - Gandhinagar Hwy, Ahmedabad, 382481
India
www.zyduscadila.com/ View on MapFDA Approved Drug Records ( 31 records )
Drug Name
CLOPIDOGREL BISULFATE
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2012-10-10
Active Ingredient
CLOPIDOGREL BISULFATE
Application Number
201686
Product Number
1
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2012-10-10
Regulatory Status
Discontinued
Drug Name
EFINACONAZOLE
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2022-07-15
Active Ingredient
EFINACONAZOLE
Application Number
212178
Product Number
1
Dosage Form
-
Strength
10%
Approval Date
2022-07-15
Regulatory Status
Discontinued
Drug Name
FINASTERIDE AND TADALAFIL
Product Number
1
Dosage Form
-
Strength
5MG;5MG
Approval Date
2024-03-15
Active Ingredient
FINASTERIDE; TADALAFIL
Application Number
218232
Product Number
1
Dosage Form
-
Strength
5MG;5MG
Approval Date
2024-03-15
Regulatory Status
Discontinued
Drug Name
GEMFIBROZIL
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2018-08-28
Active Ingredient
GEMFIBROZIL
Application Number
204189
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
2018-08-28
Regulatory Status
Discontinued
Drug Name
IBRUTINIB
Product Number
1
Dosage Form
-
Strength
70MG
Approval Date
2021-03-31
Active Ingredient
IBRUTINIB
Application Number
211344
Product Number
1
Dosage Form
-
Strength
70MG
Approval Date
2021-03-31
Regulatory Status
Discontinued
Drug Name
IBRUTINIB
Product Number
2
Dosage Form
-
Strength
140MG
Approval Date
2021-03-31
Active Ingredient
IBRUTINIB
Application Number
211344
Product Number
2
Dosage Form
-
Strength
140MG
Approval Date
2021-03-31
Regulatory Status
Discontinued
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2021-02-24
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
213441
Product Number
1
Dosage Form
-
Strength
EQ 10MG BASE
Approval Date
2021-02-24
Regulatory Status
Discontinued
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-02-24
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
213441
Product Number
2
Dosage Form
-
Strength
EQ 25MG BASE
Approval Date
2021-02-24
Regulatory Status
Discontinued
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2021-02-24
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
213441
Product Number
3
Dosage Form
-
Strength
EQ 50MG BASE
Approval Date
2021-02-24
Regulatory Status
Discontinued
Drug Name
NORTRIPTYLINE HYDROCHLORIDE
Product Number
4
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2021-02-24
Active Ingredient
NORTRIPTYLINE HYDROCHLORIDE
Application Number
213441
Product Number
4
Dosage Form
-
Strength
EQ 75MG BASE
Approval Date
2021-02-24
Regulatory Status
Discontinued
Drug Name
OMEGA-3-ACID ETHYL ESTERS
Product Number
1
Dosage Form
-
Strength
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Approval Date
2019-06-14
Active Ingredient
OMEGA-3-ACID ETHYL ESTERS
Application Number
210107
Product Number
1
Dosage Form
-
Strength
1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Approval Date
2019-06-14
Regulatory Status
Discontinued
Drug Name
PALBOCICLIB
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2024-06-05
Active Ingredient
PALBOCICLIB
Application Number
215570
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
2024-06-05
Regulatory Status
Discontinued
Drug Name
PALBOCICLIB
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2024-06-05
Active Ingredient
PALBOCICLIB
Application Number
215570
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
2024-06-05
Regulatory Status
Discontinued
Drug Name
PALBOCICLIB
Product Number
3
Dosage Form
-
Strength
125MG
Approval Date
2024-06-05
Active Ingredient
PALBOCICLIB
Application Number
215570
Product Number
3
Dosage Form
-
Strength
125MG
Approval Date
2024-06-05
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
1
Dosage Form
-
Strength
0.2MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
1
Dosage Form
-
Strength
0.2MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
2
Dosage Form
-
Strength
0.4MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
3
Dosage Form
-
Strength
0.6MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
4
Dosage Form
-
Strength
0.8MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
4
Dosage Form
-
Strength
0.8MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
5
Dosage Form
-
Strength
1MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
5
Dosage Form
-
Strength
1MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
6
Dosage Form
-
Strength
1.2MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
6
Dosage Form
-
Strength
1.2MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
7
Dosage Form
-
Strength
1.4MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
7
Dosage Form
-
Strength
1.4MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
SELEXIPAG
Product Number
8
Dosage Form
-
Strength
1.6MG
Approval Date
2022-12-21
Active Ingredient
SELEXIPAG
Application Number
214302
Product Number
8
Dosage Form
-
Strength
1.6MG
Approval Date
2022-12-21
Regulatory Status
Discontinued
Drug Name
VALBENAZINE TOSYLATE
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-08-07
Active Ingredient
VALBENAZINE TOSYLATE
Application Number
216137
Product Number
1
Dosage Form
-
Strength
EQ 40MG BASE
Approval Date
2024-08-07
Regulatory Status
Discontinued
Drug Name
VALBENAZINE TOSYLATE
Product Number
2
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2024-08-07
Active Ingredient
VALBENAZINE TOSYLATE
Application Number
216137
Product Number
2
Dosage Form
-
Strength
EQ 60MG BASE
Approval Date
2024-08-07
Regulatory Status
Discontinued
Drug Name
VALBENAZINE TOSYLATE
Product Number
3
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2024-08-07
Active Ingredient
VALBENAZINE TOSYLATE
Application Number
216137
Product Number
3
Dosage Form
-
Strength
EQ 80MG BASE
Approval Date
2024-08-07
Regulatory Status
Discontinued
Drug Name
VALSARTAN AND HYDROCHLOROTHIAZIDE
Product Number
1
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2019-03-15
Active Ingredient
HYDROCHLOROTHIAZIDE; VALSARTAN
Application Number
203000
Product Number
1
Dosage Form
-
Strength
12.5MG;80MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
VALSARTAN AND HYDROCHLOROTHIAZIDE
Product Number
2
Dosage Form
-
Strength
12.5MG;160MG
Approval Date
2019-03-15
Active Ingredient
HYDROCHLOROTHIAZIDE; VALSARTAN
Application Number
203000
Product Number
2
Dosage Form
-
Strength
12.5MG;160MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
VALSARTAN AND HYDROCHLOROTHIAZIDE
Product Number
3
Dosage Form
-
Strength
12.5MG;320MG
Approval Date
2019-03-15
Active Ingredient
HYDROCHLOROTHIAZIDE; VALSARTAN
Application Number
203000
Product Number
3
Dosage Form
-
Strength
12.5MG;320MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
VALSARTAN AND HYDROCHLOROTHIAZIDE
Product Number
4
Dosage Form
-
Strength
25MG;160MG
Approval Date
2019-03-15
Active Ingredient
HYDROCHLOROTHIAZIDE; VALSARTAN
Application Number
203000
Product Number
4
Dosage Form
-
Strength
25MG;160MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
VALSARTAN AND HYDROCHLOROTHIAZIDE
Product Number
5
Dosage Form
-
Strength
25MG;320MG
Approval Date
2019-03-15
Active Ingredient
HYDROCHLOROTHIAZIDE; VALSARTAN
Application Number
203000
Product Number
5
Dosage Form
-
Strength
25MG;320MG
Approval Date
2019-03-15
Regulatory Status
Discontinued
Drug Name
VIGABATRIN
Product Number
1
Dosage Form
-
Strength
500MG/PACKET
Approval Date
2023-03-02
Active Ingredient
VIGABATRIN
Application Number
214671
Product Number
1
Dosage Form
-
Strength
500MG/PACKET
Approval Date
2023-03-02
Regulatory Status
Discontinued
Drug Status Breakdown
31 total- Discontinued
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
CLOPIDOGREL BISULFATE
Application Number
201686
Product Number
1
Active Ingredient
CLOPIDOGREL BISULFATE
Dosage Form
-
Strength
EQ 75MG BASE
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.